[go: up one dir, main page]

NO844710L - Fremgangsmaate for fremstilling av hoeyrent protein - Google Patents

Fremgangsmaate for fremstilling av hoeyrent protein

Info

Publication number
NO844710L
NO844710L NO844710A NO844710A NO844710L NO 844710 L NO844710 L NO 844710L NO 844710 A NO844710 A NO 844710A NO 844710 A NO844710 A NO 844710A NO 844710 L NO844710 L NO 844710L
Authority
NO
Norway
Prior art keywords
procedure
preparation
high protein
protein
Prior art date
Application number
NO844710A
Other languages
English (en)
Other versions
NO169021B (no
NO169021C (no
Inventor
Koichi Kato
Takao Yamada
Haruo Onda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16823684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO844710(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO844710L publication Critical patent/NO844710L/no
Publication of NO169021B publication Critical patent/NO169021B/no
Publication of NO169021C publication Critical patent/NO169021C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO844710A 1983-11-28 1984-11-27 Fremgangsmaate for fremstilling av vesentlig rent uglykosylert humant interleukin-2-protein NO169021C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58225079A JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―2蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物

Publications (3)

Publication Number Publication Date
NO844710L true NO844710L (no) 1985-05-29
NO169021B NO169021B (no) 1992-01-20
NO169021C NO169021C (no) 1992-04-29

Family

ID=16823684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844710A NO169021C (no) 1983-11-28 1984-11-27 Fremgangsmaate for fremstilling av vesentlig rent uglykosylert humant interleukin-2-protein

Country Status (16)

Country Link
US (1) US5464939A (no)
EP (3) EP0751220A1 (no)
JP (1) JPS60115528A (no)
KR (1) KR920006879B1 (no)
DK (1) DK164174C (no)
ES (1) ES8606489A1 (no)
FI (1) FI81118C (no)
GR (1) GR81040B (no)
HU (1) HU200793B (no)
IL (1) IL73530A0 (no)
MY (1) MY103892A (no)
NO (1) NO169021C (no)
NZ (1) NZ210352A (no)
PT (1) PT79555B (no)
SG (1) SG46452A1 (no)
ZA (1) ZA849221B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
CA1340853C (en) * 1983-12-23 1999-12-21 Hsiang-Fu Kung Purification of recombinant interleukin-2
JPS60243021A (ja) * 1984-03-28 1985-12-03 シタス コ−ポレイシヨン システイン含有蛋白質の制御された酸化方法
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−2の製造方法
WO1986007093A1 (en) * 1985-05-29 1986-12-04 The Green Cross Corporation Process for preparing heterogenic protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
DE3581412D1 (de) * 1985-07-16 1991-02-21 Green Cross Corp Verfahren zur herstellung von heteroproteinen.
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
CN86104525A (zh) * 1985-07-31 1987-02-25 武田药品工业株式会社 人类白细胞介素-2的分析方法和试剂
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
JPH0655153B2 (ja) * 1986-02-26 1994-07-27 武田薬品工業株式会社 ヒトインターロイキン―2結晶の製造法
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US5149788A (en) * 1987-05-19 1992-09-22 Hoffmann-La Roche, Inc. Purification of chimeric proteins containing an IL-2 moiety by receptor-affinity chromatography
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
GB201000693D0 (en) 2010-01-15 2010-03-03 Isis Innovation A solar cell
KR102349549B1 (ko) * 2010-11-12 2022-01-11 넥타르 테라퓨틱스 Il-2 부분 및 중합체의 접합체
CN113230384A (zh) 2014-10-09 2021-08-10 丹娜法伯癌症研究院 用于治疗免疫失调的多次-可变il-2剂量方案

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Il‐2をコードする新規伝令rnaの製造法
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン2を含有してなる癌治療剤
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
JPS58201979A (ja) * 1982-05-18 1983-11-25 Japan Found Cancer ヒトインタ−ロイキン2遺伝子が組込まれているエシエリヒア・コリおよびその育種方法
JPS58168492A (ja) * 1982-03-31 1983-10-04 Nippon Kokan Kk <Nkk> パイプ切断機
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
JPS58198293A (ja) * 1982-05-12 1983-11-18 Shionogi & Co Ltd インタ−ロイキン等免疫調節因子の製造方法
NL8203321A (nl) * 1982-08-25 1984-03-16 Philips Nv Kleurenbeeldbuis.
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
EP0119621A1 (en) * 1983-03-21 1984-09-26 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interleukin-2
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
CA1340853C (en) * 1983-12-23 1999-12-21 Hsiang-Fu Kung Purification of recombinant interleukin-2
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
JP2608730B2 (ja) * 1987-08-10 1997-05-14 株式会社リコー 感熱記録材料

Also Published As

Publication number Publication date
HUT36186A (en) 1985-08-28
AU592527B2 (en) 1990-01-18
NO169021B (no) 1992-01-20
NZ210352A (en) 1988-11-29
EP0442538A1 (en) 1991-08-21
HU200793B (en) 1990-08-28
FI81118B (fi) 1990-05-31
PT79555A (en) 1984-12-01
SG46452A1 (en) 1998-02-20
EP0145390A2 (en) 1985-06-19
EP0145390A3 (en) 1987-01-21
NO169021C (no) 1992-04-29
PT79555B (en) 1986-12-15
DK560784D0 (da) 1984-11-27
US5464939A (en) 1995-11-07
DK560784A (da) 1985-05-29
FI844678A0 (fi) 1984-11-28
ES537994A0 (es) 1986-04-01
ES8606489A1 (es) 1986-04-01
IL73530A0 (en) 1985-02-28
ZA849221B (en) 1986-07-30
AU3575684A (en) 1985-06-06
GR81040B (en) 1985-03-27
FI844678L (fi) 1985-05-29
KR850003734A (ko) 1985-06-26
KR920006879B1 (ko) 1992-08-21
FI81118C (fi) 1990-09-10
DK164174C (da) 1992-10-05
JPH0542413B2 (no) 1993-06-28
MY103892A (en) 1993-10-30
EP0751220A1 (en) 1997-01-02
JPS60115528A (ja) 1985-06-22
DK164174B (da) 1992-05-18

Similar Documents

Publication Publication Date Title
NO844710L (no) Fremgangsmaate for fremstilling av hoeyrent protein
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
RO90861A (ro) Procedeu pentru prepararea etielnglicolului
NO841158L (no) Fremgangsmaate for fremstilling av 2-azetidin-4-substituerte forbindelser
NO164991C (no) Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner.
NO844388L (no) Fremgangsmaate for fremstilling av aminoeteralkoholer
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
NO164171C (no) Analogifremgangsmaate for fremstilling av bicykliske heterocyklyholdige n-(bicykliske heterocyklyl)-4-piperidinaminer
RO86213A (ro) Procedeu pentru prepararea izobutenei
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
NO170019C (no) Fremgangsmaate for fremstilling av deglucoteicoplanin (antibiotikum l 17392)
NO844243L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
NO842868L (no) Framgangsmaate for framstilling av alkoholer
NO832830L (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer
NO169126C (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
DK47684D0 (da) Fremgangsmaade til fremstilling af proteinhydrolysater
NO830309L (no) Fremgangsmaate for fremstilling av tennsats for varmeanordning
NO845006L (no) Fremgangsmaate for fremstilling av antibiotikum l 17054
NO831874L (no) Fremgangsmaate for fremstilling av trifenylbuten-derivater
SE435941B (sv) Forfarande for framstellning av forbettrad slipmassa
NO842078L (no) Fremgangsmaate for fremstilling av nye aryloxycycloalkanol-aminoalkylenarylketoner
NO840535L (no) Fremgangsmaate ved fremstilling av aroylimidazoloner
NO844943L (no) Fremgangsmaate for fremstilling av pyrrolo-indolderivater
NO844183L (no) Fremgangsmaate til fremstilling av bis-dioksopiperazinderivater